From: Post-treatment surveillance imaging in head and neck cancer: a systematic review
First author and year | Imaging technique(s) | Design/methods | Results |
---|---|---|---|
Imaging surveillance (at least once) after 3–6 months appears to be beneficial (in terms of lesion detection) | |||
 Fukumoto 2021 [52] | CT/PET-CT | • Retrospective study including 324 patients | • It is desirable to perform PET/CT within 3–6 months and at 1 year after surgery and to consider CECT as an option in between PET/CT |
 Liu 2021 [53] | CT/MRI | • Retrospective study including 741 patients | • 19.7% of recurrences were found during routine imaging only • In late-stage and elderly patients, frequent head and neck CT/MRI scan was associated with a better prognosis |
 Ravanelli 2021 [54] | PET-CT | • Retrospective observational study including 87 patients | • Performing imaging studies every 6 months for 2 years changed the diagnostic/therapeutic strategy in about one-fifth of patients |
 Chi 2020 [55] | (?) | • Retrospective study including 83 patients | • 29.4% of recurrences were detected by serial imaging alone in asymptomatic patients; most of them (92.3%) occurred within the first 2 years |
 Lin 2017 [56] | PET-CT | • Retrospective study including 111 patients | • Scheduled periodic PET/CT surveillance is a valuable tool for early detection of recurrent lesion(s) in asymptomatic OSCC patients who bear risk factors for disease recurrence |
 Peisker 2017 [57] | RX/CT | • Retrospective study including 228 patients | • The results of this study suggest an intensified imaging follow-up within the first 2 years after surgery |
 Rivelli 2011 [58] | CT | • Retrospective study including 294 patients | • Routine CT for follow-up is indicated for detecting lymph node metastases as well as local recurrence |
Imaging surveillance after 3–6 months appears to have no or only limited benefit | |||
 Al-Shwaiheen 2014 [59] | MRI | • Retrospective study including 62 patients | • Routine MRI after 6 months may be unnecessary in patients without concurrent suspicious symptoms or exam findings |
Imaging surveillance after 3-6Â m is of uncertain benefit/other | |||
 Krabbe 2009 [60] | PET-CT | • Prospective study including 48 patients | • PET is a suitable routine posttreatment surveillance tool and detects malignancy before clinical suggestion by the regular follow-up arises • The best timing of a systematic PET scan is between 3 and 6 months after treatment |